Importantly however, TNF-α has been shown to play a role in protection against secondary bacterial pneumonia after influenza infection and anti-TNF-α therapies, which target both tmTNF-α and sTNF-α, have been associated with an increased risk for bacterial infection [35]-[37]. The gene discussed is TNF; the disease is bacterial infectious disease.